FIRST AIRED: August 29, 2016

Nice work! Enjoy the show!


You’re busy. We get it.

Stay on top of the news with our Editor’s Picks newsletter.

US Edition
Intl. Edition
Unsubscribe at any time. One click, it’s gone.

Thanks for signing up!



>> Amid a wave of criticism from law-makers and the public over the rising cost of the EpiPen, Mylan said on Monday, it would launch the first generic version of its allergy auto-injector at a discount of more than 50%. The branded products list price has skyrocketed from $100 in 2008 to $600 today.
EpiPen, which Mylan acquired in 2007, is a preloaded injection of adrenaline used in case of a severe allergic reaction that could cause death if untreated. The company, which has been excoriated for the drug's rapidly escalating price, last week said it would reduce the patient cost of EpiPen through the use of a savings card which would cover up to $300 of an EpiPen 2-Pak.
Mylan said it expected to launch the generic product quote in several weeks.